The association of coagulation and atrial fibrillation: a systematic review and meta-analysis

Martijn J Tilly1, Sven Geurts1, Angelo M Pezzullo1,2

  • 1Department of Epidemiology, Erasmus MC, University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands.

Insights

This study found that higher levels of coagulation factors are linked to atrial fibrillation (AF). Evidence suggests a prothrombotic state may contribute to AF development, increasing thrombotic risk.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Thrombosis Research

Background:

  • Atrial fibrillation (AF) is associated with a prothrombotic state, yet the role of coagulation in AF onset remains unclear.
  • Understanding the relationship between coagulation factors and AF is crucial for risk stratification and management.

Approach:

  • A systematic review and meta-analysis was conducted, synthesizing data from 17 longitudinal and 44 cross-sectional studies.
  • Pooled hazard ratios (HRs) and standardized mean differences (SMDs) were calculated to assess associations between coagulation factors and AF incidence and prevalence.

Key Points:

  • Longitudinal studies revealed significant associations between fibrinogen, plasminogen activator inhibitor 1 (PAI-1), and D-dimer with AF incidence.
  • Cross-sectional studies indicated elevated levels of fibrinogen, von Willebrand factor, P-selectin, ß-thromboglobulin, Platelet Factor 4, PAI-1, and D-dimer in patients with prevalent AF.

Conclusions:

  • Elevated coagulation factor levels are associated with both prevalent and incident AF.
  • The strongest associations were observed in cross-sectional studies of prevalent AF.
  • Limited longitudinal data suggest a prothrombotic state may underlie AF development.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
867
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21